Generic property - PDFSEARCH.IO - Document Search Engine

Generic property
Results: 252

#	Item
131	Generic Online Form DESCRIPTION: YEAR PURCHASED: MFG: PROPERTY NO: Add to Reading List Source URL: content.oa.mo.gov - Date: 2013-03-19 16:18:32
132	INTELLECTUAL PROPERTY* Jesus Culis knows that lower-priced generic drugs save lives. If you looked at him, you never would guess that Jesus has spent the last eight years living with HIV. He is an energetic young man wit Add to Reading List Source URL: www.ucc.org Language: English - Date: 2008-09-08 20:48:04 Pharmaceuticals policy Pharmacology Pharmacy Law Patent Pharmaceutical industry Intellectual property Generic drug HIV/AIDS in Brazil Monopoly Pharmaceutical sciences Intellectual property law
133	The Generic Point Problem and Closed Subgroups of S∞ Andy Zucker A topological group G is said to have the Generic Point Property if the universal minimal flow M (G) has a generic point, a point whose orbit is comeager Add to Reading List Source URL: www.math.caltech.edu - Date: 2014-05-06 13:56:18
134	Order Code RL33901 Follow-On Biologics: Intellectual Property and Innovation Issues Add to Reading List Source URL: ipmall.info Language: English - Date: 2008-07-02 20:24:36 Medicine Pharmaceutical industry Pharmaceuticals policy Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Food and Drug Administration
135	. Patent “Evergreening”: Issues in Innovation and Competition John R. Thomas Visiting Scholar Add to Reading List Source URL: ipmall.info Language: English - Date: 2009-12-07 20:38:47 Property law Evergreening Chemical patent Generic drug Patent United States Patent and Trademark Office United States patent law Drug Price Competition and Patent Term Restoration Act Title 35 of the United States Code Patent law Law Civil law
136	. Follow-On Biologics: Intellectual Property and Innovation Issues Wendy H. Schacht Specialist in Science and Technology Policy Add to Reading List Source URL: ipmall.info Language: English - Date: 2009-04-17 20:27:39 Pharmaceutical industry Pharmaceuticals policy Food and Drug Administration Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Clinical research
137	Order Code RL33901 Follow-On Biologics: Intellectual Property and Innovation Issues Add to Reading List Source URL: ipmall.info Language: English - Date: 2007-07-28 13:14:49 Medicine Pharmaceutical industry Pharmaceuticals policy Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Food and Drug Administration
138	. Follow-On Biologics: Intellectual Property and Innovation Issues Wendy H. Schacht Specialist in Science and Technology Policy Add to Reading List Source URL: ipmall.info Language: English - Date: 2010-11-10 20:48:18 Pharmaceutical industry Food and Drug Administration Biotechnology Pharmaceuticals policy Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Clinical research
139	Order Code RL33901 Follow-On Biologics: Intellectual Property and Innovation Issues Add to Reading List Source URL: ipmall.info Language: English - Date: 2009-01-07 20:22:49 Food and Drug Administration Health Pharmaceutical industry Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Pharmaceuticals policy
140	Order Code RL33901 Follow-On Biologics: Intellectual Property and Innovation Issues Add to Reading List Source URL: ipmall.info Language: English - Date: 2007-03-27 14:47:20 Medicine Pharmaceutical industry Pharmaceuticals policy Biotechnology Biosimilar Drug Price Competition and Patent Term Restoration Act New Drug Application Generic drug Biologic Pharmaceutical sciences Pharmacology Food and Drug Administration

UPDATE